EyeGate Pharma completes Phase II dry eye trial
For the dry eye clinical trial, EyeGate worked with Ora, a global clinical R&D organization, located in Andover, Massachusetts. This Phase II single-center, randomized, double-masked, placebo-controlled study of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.